DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Meriden, CT

6 verified pulmonary disease doctors in Meriden.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Connecticut Medical Examining Board

Dr. Richard Giosa, MD

Pulmonary Disease

21 yrs NPPES
NPI 1659363042
455 LEWIS AVE, SUITE 200, Meriden, CT 06451(203) 238-9446
NPPES public registry
CMS Open Payments· $910.67 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$910.67

Total received

51

Transactions

14

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$164.90
AstraZeneca Pharmaceuticals LP$147.69
Mallinckrodt Hospital Products Inc.$126.28
Boehringer Ingelheim Pharmaceuticals, Inc.$73.13
Grifols USA, LLC$59.97
Pfizer Inc.$58.99

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 79th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Richard Giosa do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Richard Smith, MD

Pulmonary Disease

20 yrs NPPES
NPI 1689770950
455 LEWIS AVE, STE 205, Meriden, CT 06451(203) 639-7272
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Laurence Nair, MD

Pulmonary Disease

19 yrs NPPES
NPI 1811014699
455 LEWIS AVE, SUITE 206, Meriden, CT 06451(203) 238-9446
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,077 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,077

Total received

60

Transactions

9

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$404.27
GlaxoSmithKline, LLC.$363.71
Regeneron Healthcare Solutions, Inc.$132.71
Amgen Inc.$51.34
Grifols USA, LLC$37.25
Takeda Pharmaceuticals U.S.A., Inc.$27.83

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 80th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Laurence Nair do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Ali Hemdan, MD

Pulmonary Disease

18 yrs NPPES
NPI 1366692691
455 LEWIS AVE, SUITE 206, Meriden, CT 06451(203) 238-9446
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $716.49 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$716.49

Total received

44

Transactions

12

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$161.94
Regeneron Healthcare Solutions, Inc.$115.65
Takeda Pharmaceuticals U.S.A., Inc.$90.17
Boehringer Ingelheim Pharmaceuticals, Inc.$73.13
Genzyme Corporation$57.39
Pfizer Inc.$52.70

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Ali Hemdan do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Humnah Khudayar, MD

Pulmonary Disease

11 yrs NPPES
NPI 1376927921
455 LEWIS AVE, Meriden, CT 06451(203) 238-9446
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $461.50 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$461.50

Total received

20

Transactions

10

Paying companies

Top paying companies

Amgen Inc.$84.42
Regeneron Healthcare Solutions, Inc.$72.35
Pfizer Inc.$57.03
AstraZeneca Pharmaceuticals LP$55.72
CSL Behring$45.14
GlaxoSmithKline, LLC.$35.69

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 73th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Humnah Khudayar do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Victor Zavala Gonzalez, MD

Pulmonary Disease

8 yrs NPPES
NPI 1184118085
435 LEWIS AVE, Meriden, CT 06451(203) 694-8591
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $235.51 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$235.51

Total received

10

Transactions

5

Paying companies

Top paying companies

Mylan Specialty L.P.$73.25
AstraZeneca Pharmaceuticals LP$57.23
Regeneron Healthcare Solutions, Inc.$54.36
Janssen Pharmaceuticals, Inc$29.58
Boehringer Ingelheim Pharmaceuticals, Inc.$21.09

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 66th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Victor Zavala Gonzalez do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Meriden, CT — Verified | DoctorsProof | DoctorsProof